Login / Signup

Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.

Madlen JentzschJuliane GrimmMarius BillJohannes KüpperDonata BackhausDominic BrauerJulia SchulzGeorg-Nikolaus FrankeVladan VucinicDietger NiederwieserUwe PlatzbeckerSebastian Schwind
Published in: Bone marrow transplantation (2021)
Keyphrases
  • stem cell transplantation
  • high dose
  • acute myeloid leukemia
  • dna methylation
  • allogeneic hematopoietic stem cell transplantation
  • gene expression